Creatine May Limit Brain Damage
WebMD News Archive
Nov. 2, 2000 -- The dietary supplement creatine is widely used by athletes to increase muscle mass and performance. Now a new study, conducted in animals, suggests that it may also protect against damage due to brain injury in people.
"Professional quarterbacks in the NFL sustain many concussions, with less damage than we might expect," senior author Stephen W. Scheff, PhD, tells WebMD. "That could be because they're taking creatine." Scheff is professor of anatomy and neurobiology at the University of Kentucky School of Medicine and associate director of basic research at the Sanders-Brown Center on Aging, both in Lexington.
In this study, published in the November issue of The Annals of Neurology, researchers fed rats and mice a diet high in creatine, and then simulated a concussion. They found that rats who ate a creatine diet for four weeks had a 50% reduction in brain damage, compared to rats on a normal diet. Mice who received three days of creatine pretreatment had a 21% decline in damaged cells, while those who received five days of creatine pretreatment had a 36% decline.
This doesn't mean you should eat creatine ahead of time before having a concussion, because concussions obviously aren't planned. But because these animal studies show creatine works by increasing energy production in the part of the brain cells responsible for generating the body's energy, called the mitochondria, it may be possible to find a substance that has a similar effect if taken soon after a concussion or brain injury. Scheff and other researchers have looked at several substances and are now conducting tests on one promising possibility.
Just as important, creatine may be valuable in several diseases where mitochondrial dysfunction plays a role. According to Sinclair Smith, ScD, many previous studies have indicated that creatine has the capacity to protect nerves. These reports have shown that it has good results in Lou Gehrig's disease (also known as amyotrophic lateral sclerosis, or ALS) and multiple sclerosis among others, he tells WebMD. Smith is an assistant professor of physiology in the occupational therapy department at Temple University School of Medicine in Philadelphia.